Inferencia lógica del indicio: análisis de los procesos de simulación con base en el razonamiento probatorio del contexto

This paper outlines the results of a research study aiming to analyse the prevailing standard of probability in relation to both evidence and context as means of proof in simulation proceedings in Colombian civil law. The fundamental contribution of this research study is to prioritise the logical-valuative judgements made by the judge when analysing the context circumstantial evidence in court ruling on simulated legal transactions. The question to be addressed, by means of a basic legal, analytical, systematic and hermeneutic methodology, is the following: Does context evidence constitute a limit to the standards of circumstantial evidence in decisions on simulation proceedings? The paper concludes that, although it does not constitute a valuation limit, it does allow the development of the prevailing probability standard with respect to simulation.El presente artículo esquematiza los resultados de una investigación cuyo objetivo general es analizar el estándar de la probabilidad prevalente en torno al indicio y al contexto como medios probatorios del proceso declarativo de simulación en materia del derecho civil colombiano. Por lo tanto, el aporte fundamental de esta investigación es priorizar los juicios lógicos-valorativos que realiza el juez en el análisis de la prueba indiciaria de contexto, frente al fallo judicial de un negocio jurídico simulado. La pregunta problema por resolver, mediante una metodología básica jurídica, analítica, sistemática y hermenéutica es la siguiente: ¿La prueba de contexto configura un límite de valoración a los estándares de la prueba de indicio en las decisiones sobre los procesos de simulación? Sobre la cual se concluyó, finalmente, que, si bien no configura un límite de valoración, este sí permite el desarrollo del estándar de la probabilidad prevalente respecto de la simulación

Realfood and cancer: analysis of the reliability and quality of YouTube content

This study analyzes the quality and reliability of videos related to nutrition and cancer on YouTube. Study Design: An observational, retrospective, cross-sectional, time-limited study analyzing activity on the social network YouTube was proposed. Methods: The information from the videos was extracted through an API search tool, using the NodeXL software. The criteria to select the videos on YouTube were the keywords “real food”, “realfood”, and “cancer” and the hashtags #realfood and #cancer were present, videos in English and videos available on 1 December 2022. Results: The DISCERN value in the total number of videos viewed was 2.25 (±0.88) points, indicating low reliability. The videos uploaded by HRU represented only 20.8%. Videos suggesting that the use of foods defined as “real food” could cure cancer without the intervention of any other treatment accounted for 12.5%. Videos that provided external links to scientific/technical evidence verifying the information represented only 13.89% of the total number of videos. Of these videos, 70% corresponded to HRU. The DISCERN value for videos from HRU users was 3.05 (0.88), a value that reflects a good reliability of videos from these users. Conclusions: This study provides information on the content and quality of the videos that we can find on YouTube. We found videos of non-health users who do not base their content on any scientific evidence, with the danger that this entails for the population, but it also highlights that the videos published by HRU have greater reliability and quality, being better perceived by the population, so it is important to encourage healthcare professionals and health institutions to share verified information on YouTube.This research was funded by Fundación Banco Santander and Fundación Alfonso X el Sabio, grant number 1014011. Partial funding for open access charge: Universidad de Málag

Determinación de la relación que existe entre la selección de personal y el desempeño de la microempresa “Modulares J&C S.AS”

A Encuesta contexto empresa, B Encuesta empleados, C Encuesta gerencia, D Bases desarrollo proceso selecciónEl presente documento es un paralelo que analiza la realidad de una MiPyme colombiana frente al manejo del proceso de selección de personal de manera orgánica, sin estructura, experiencia o uniformidad, y como la estructuración de este representa un factor clave para el desarrollo de una empresa. Al ser el recurso humano un elemento crítico dentro del entorno organizacional, su correcta selección influye de manera directa en el desempeño que una organización tiene, al mismo tiempo, brindar la formalidad estructural que cualquier empresa debe tener al momento que empieza a crecer o expandirse. Para este fin, se analizará el manejo que una MiPymes colombiana tiene frente a la selección de su recurso humano donde a través de una investigación cualitativa de la visión/experiencia de quien lidera y aplica el proceso, se contrastará con la experiencia de aquellos a quienes se les aplicó el mismo. Sobre esta realidad, se inferirá la importancia de la formalidad en el proceso de selección de recurso humano, para reducir problemas de rotación de personal, fijar objetivos y estructurar, aun más, la operación de la empresa.This document is a parallel that analyses how a MSME (Small and Medium Enterprise) manages its selection process in an organic way, without structure or experience and how its structuring, represents a key factor for the growing of a company. As human resources are a critical element within the organizational environment, their correct selection constitutes a direct influence in the performance of a company; at the same time, it allows to provide the formality that any company must have at the time it begins to grow and or to expand. Having said this, the management of the selection process of a Colombian MSME will be analyze through a qualitive investigation. This analysis will be base in two visions/experiences, the one lead it by the management of the company, as well as the experience of those that the process was applied. This will allow to conclude the importance of the formality for this process looking to reduce problems related to staff rotation, setting of objectives, structure, among others

Determination of the surface functionality of nanocarbon allotropes by boehm titration

Critical point (CP) in a titration curve to quantify carboxylic, lactonic, and phenolic groups on multi-walled carbon nanotube (CNT) and Vulcan carbon (VC). Titration technique used was Boehm type and tipping point measurement from titration curve was done by second derivative method. The calculation functional groups on nanocarbons (NCs) presents lowest uncertainty previously published. An order of ±10−4meq/g is the precision of the values obtained, one order of magnitude below reported. Both NCs display a high quantity of carboxylic groups created after being treated with regard to the other functional groups generated, mainly for functionalized Vulcan carbon VC-F

Prioritizing research challenges and funding for allergy and asthma and the need for translational research-The European Strategic Forum on Allergic Diseases

The European Academy of Allergy and Clinical Immunology (EAACI) organized the first European Strategic Forum on Allergic Diseases and Asthma. The main aim was to bring together all relevant stakeholders and decision-makers in the field of allergy, asthma and clinical Immunology around an open debate on contemporary challenges and potential solutions for the next decade. The Strategic Forum was an upscaling of the EAACI White Paper aiming to integrate the Academy's output with the perspective offered by EAACI's partners. This collaboration is fundamental for adapting and integrating allergy and asthma care into the context of real-world problems. The Strategic Forum on Allergic Diseases brought together all partners who have the drive and the influence to make positive change: national and international societies, patients' organizations, regulatory bodies and industry representatives. An open debate with a special focus on drug development and biomedical engineering, big data and information technology and allergic diseases and asthma in the context of environmental health concluded that connecting science with the transformation of care and a joint agreement between all partners on priorities and needs are essential to ensure a better management of allergic diseases and asthma in the advent of precision medicine together with global access to innovative and affordable diagnostics and therapeutics.Peer reviewe

COVID-19 vaccination in patients receiving allergen immunotherapy (AIT) or biologicals:EAACI recommendations

Immune modulation is a key therapeutic approach for allergic diseases, asthma and autoimmunity. It can be achieved in an antigen-specific manner via allergen immunotherapy (AIT) or in an endotype-driven approach using biologicals that target the major pathways of the type 2 (T2) immune response: immunoglobulin (Ig)E, interleukin (IL)-5 and IL-4/IL-13 or non-type 2 response: anti-cytokine antibodies and B-cell depletion via anti-CD20. Coronavirus disease 2019 (COVID-19) vaccination provides an excellent opportunity to tackle the global pandemics and is currently being applied in an accelerated rhythm worldwide. The vaccine exerts its effects through immune modulation, induces and amplifies the response against the severe acute respiratory syndrome coronavirus (SARS-CoV-2). Thus, as there may be a discernible interference between these treatment modalities, recommendations on how they should be applied in sequence are expected. The European Academy of Allergy and Clinical Immunology (EAACI) assembled an expert panel under its Research and Outreach Committee (ROC). This expert panel evaluated the evidence and have formulated recommendations on the administration of COVID-19 vaccine in patients with allergic diseases and asthma receiving AIT or biologicals. The panel also formulated recommendations for COVID-19 vaccine in association with biologicals targeting the type 1 or type 3 immune response. In formulating recommendations, the panel evaluated the mechanisms of COVID-19 infection, of COVID-19 vaccine, of AIT and of biologicals and considered the data published for other anti-infectious vaccines administered concurrently with AIT or biologicals

Controlo químico de infestantes

Uma planta é considerada infestante quando nasce espontaneamente num local e momento indesejados, podendo interferir negativamente com a cultura instalada. As infestantes competem com as culturas para o espaço, a luz, água e nutrientes, podendo atrasar e prejudicar as operações de colheita, depreciar o produto final e assegurarem a reinfestação nas culturas seguintes. Dado o modo de propagação diferenciado das diversas espécies de infestantes, com as anuais a propagarem-se por semente e as perenes ou vivazes a assegurarem a sua propagação através de órgãos vegetativos (rizomas, bolbos, tubérculos, etc.), assim, também o seu controlo quer químico, quer mecânico terá que ser diferenciado, ou seja, para controlar infestantes anuais será suficiente destruir a sua parte aérea, enquanto para controlar infestantes perenes teremos que destruir os seus órgãos reprodutivos. O controlo de infestantes poderá ser químico, através da utilização de herbicidas, ou mecânico pela utilização de alfaias agrícolas, tais como a charrua de aivecas, a charrua de discos, a grade de discos, o escarificador e a fresa. Quando a técnica utilizada na instalação das culturas é a sementeira directa, o controlo das infestantes terá que ser obrigatoriamente químico, enquanto se o recurso à mobilização do solo for a técnica mais utilizada (sistema de mobilização tradicional ou sistema de mobilização reduzida), o controlo das infestantes tanto poderá ser químico como mecânico. Neste trabalho iremos abordar apenas, o controlo químico de infestantes

Prioritizing Research Challenges and Funding for Allergy and Asthma and the Need for Translational Research : The European Strategic Forum on Allergic Diseases

The European Academy of Allergy and Clinical Immunology (EAACI) organized the first European Strategic Forum on Allergic Diseases and Asthma. The main aim was to bring together all relevant stakeholders and decision-makers in the field of allergy, asthma and clinical Immunology around an open debate on contemporary challenges and potential solutions for the next decade. The Strategic Forum was an upscaling of the EAACI White Paper aiming to integrate the Academy's output with the perspective offered by EAACI's partners. This collaboration is fundamental for adapting and integrating allergy and asthma care into the context of real-world problems. The Strategic Forum on Allergic Diseases brought together all partners who have the drive and the influence to make positive change: national and international societies, patients' organizations, regulatory bodies and industry representatives. An open debate with a special focus on drug development and biomedical engineering, big data and information technology and allergic diseases and asthma in the context of environmental health concluded that connecting science with the transformation of care and a joint agreement between all partners on priorities and needs are essential to ensure a better management of allergic diseases and asthma in the advent of precision medicine together with global access to innovative and affordable diagnostics and therapeutics.Peer reviewe

Clonal chromosomal mosaicism and loss of chromosome Y in elderly men increase vulnerability for SARS-CoV-2

The pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID-19) had an estimated overall case fatality ratio of 1.38% (pre-vaccination), being 53% higher in males and increasing exponentially with age. Among 9578 individuals diagnosed with COVID-19 in the SCOURGE study, we found 133 cases (1.42%) with detectable clonal mosaicism for chromosome alterations (mCA) and 226 males (5.08%) with acquired loss of chromosome Y (LOY). Individuals with clonal mosaic events (mCA and/or LOY) showed a 54% increase in the risk of COVID-19 lethality. LOY is associated with transcriptomic biomarkers of immune dysfunction, pro-coagulation activity and cardiovascular risk. Interferon-induced genes involved in the initial immune response to SARS-CoV-2 are also down-regulated in LOY. Thus, mCA and LOY underlie at least part of the sex-biased severity and mortality of COVID-19 in aging patients. Given its potential therapeutic and prognostic relevance, evaluation of clonal mosaicism should be implemented as biomarker of COVID-19 severity in elderly people. Among 9578 individuals diagnosed with COVID-19 in the SCOURGE study, individuals with clonal mosaic events (clonal mosaicism for chromosome alterations and/or loss of chromosome Y) showed an increased risk of COVID-19 lethality